Envista (NVST) Stock
Key stats
- Market cap
- $4.06B
- Price / Earnings ratio
- 6.5x
- EPS (TTM)
- $3.93
- Volume
- Loading
- 52-week high
- $30.42
- 52-week low
- $18.77
- EPS vs analyst estimate
- +18.5%Q3 FY25 · $0.32 vs $0.27
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with NVST
Recent news

Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
NVST

Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista (NVST) Earnings Expected to Grow: Should You Buy?
NVST

Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
NVST

Here's Why Envista (NVST) is a Strong Growth Stock
Here's Why Envista (NVST) is a Strong Growth Stock
NVST
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 54.81
- MACD 12/26/9
- 0.48
- EMA 9 of MACD
- 0.27
- MACD histogram
- 0.22
- SMA 50
- $24.31
- Price above SMA 50
- EMA 50
- $24.65
- Price above EMA 50
- SMA 200
- $25.78
- Price below SMA 200
- EMA 200
- $24.81
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.33 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
NVST

Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista (NVST) Earnings Expected to Grow: Should You Buy?
NVST

Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
NVST

Here's Why Envista (NVST) is a Strong Growth Stock
Here's Why Envista (NVST) is a Strong Growth Stock
NVST

New Strong Buy Stocks for September 28th
New Strong Buy Stocks for September 28th
NVST

NVST vs. ABT: Which Stock Is the Better Value Option?
NVST vs. ABT: Which Stock Is the Better Value Option?
NVST

Best Value Stocks to Buy for September 21st
Best Value Stocks to Buy for September 21st
NVST

Should Value Investors Buy Envista (NVST) Stock?
Should Value Investors Buy Envista (NVST) Stock?
NVST

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
NVST

Here's Why Envista (NVST) is a Strong Value Stock
Here's Why Envista (NVST) is a Strong Value Stock
NVST
News tone: automated (AI) classification of the article's content, not a price prediction.
About Envista
Envista is a global family of more than 30 trusted dental brands, united by a shared purpose: to partner with professionals to improve lives. Envista helps its partners deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers an estimated 90% of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul A. Keel | President, CEO & Chairman | 1970 |
| Mr. Eric D. Hammes | Senior VP & CFO | 1975 |
| Mr. Mark E. Nance J.D. | Senior VP, General Counsel & Secretary | 1969 |
| Mr. Robert Befidi Jr. | Senior VP & President of Diagnostics | 1975 |
| Ms. Veronica Acurio | Senior VP & President of Orthodontics | 1971 |
| Mr. Coree Thomas | VP & Chief Accounting Officer | 1978 |
| Mr. Andrew Chen | Chief Information Officer | — |
| Mr. Jim Gustafson | Vice President of Investor Relations | — |
| Paul Sumilas | Chief Compliance Officer | — |
| Mr. Mischa M. Reis | Senior Vice President of Strategy & Corporate Development | 1973 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 54.81
- MACD 12/26/9
- 0.48
- EMA 9 of MACD
- 0.27
- MACD histogram
- 0.22
- SMA 50
- $24.31
- Price above SMA 50
- EMA 50
- $24.65
- Price above EMA 50
- SMA 200
- $25.78
- Price below SMA 200
- EMA 200
- $24.81
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $26.00
- Average
- $28.71
- High
- $32.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.3 | +18.1 | ||||||||||
| 2022 | -4.2 | +10.6 | +2.3 | -17.6 | +8.9 | -8.3 | +3.9 | -9.7 | -9.8 | -1.3 | -0.1 | -4.3 |
| 2023 | +14.8 | -2.7 | +5.9 | -3.1 | -17.0 | +5.0 | +1.6 | -5.9 | -13.9 | -15.6 | -1.3 | +0.7 |
| 2024 | -2.5 | -13.0 | +2.2 | -5.4 | -2.0 | -11.5 | +6.0 | +7.9 | +10.9 | +8.4 | +6.4 | -13.5 |
| 2025 | +7.4 | -0.2 | -9.3 | -6.0 | +11.8 | +8.0 | -5.6 | +1.7 | -1.7 | -0.0 | +4.0 | +4.5 |
| 2026 | +8.2 | +25.6 | -13.8 | +0.2 | -10.6 | +12.8 | +0.5 | -0.8 | -11.9 | +1.5 | +2.5 |



